Acumen Pharmaceuticals Inc (NAS:ABOS)
$ 2.91 0.1 (3.56%) Market Cap: 174.83 Mil Enterprise Value: -57.43 Mil PE Ratio: 0 PB Ratio: 0.72 GF Score: 30/100

Acumen Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 06:30PM GMT
Release Date Price: $3.87 (-10.42%)
Chris Tippett JPMorgan Chase;Co.;Analyst

&-

So good morning, everyone. I hope everyone has had a good conference so far. My name is Chris Tippett, Iâm an associate here on the healthcare investment banking team at JPMorgan. Today, it is my pleasure to introduce Acumen Pharmaceuticals. And without further ado, Iâd like to turn things over to the Chief Executive Officer and President, Dan OâConnell.

Dan Oâ;Connell Acumen Pharmaceuticals
Inc. - President & CEO

Thanks, Chris. Good morning, everyone. Itâs a pleasure to be here today, and we appreciate the invitation to present. And thanks to everyone here in the room, great to see some familiar faces, and for everyone on the webcast for taking the time to learn more about Acumen Pharmaceuticals.

Iâm Dan OâConnell, Iâm the President and CEO, as Chris indicated, and Iâm pleased to provide a bit of an overview of the company and some of the more recent data for our ACU193 program. I think youâre going to find, as we see the data, itâs very encouraging and bodes

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot